<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR47">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arendse</surname>
    <given-names>LB</given-names>
   </name>
   <name>
    <surname>Danser</surname>
    <given-names>AHJ</given-names>
   </name>
   <name>
    <surname>Poglitsch</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Touyz</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Burnett</surname>
    <given-names>JC</given-names>
    <suffix>Jr</suffix>
   </name>
   <name>
    <surname>Llorens-Cortes</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Ehlers</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Sturrock</surname>
    <given-names>ED</given-names>
   </name>
  </person-group>
  <article-title>Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure</article-title>
  <source>Pharmacol Rev</source>
  <year>2019</year>
  <volume>71</volume>
  <issue>4</issue>
  <fpage>539</fpage>
  <lpage>570</lpage>
  <pub-id pub-id-type="doi">10.1124/pr.118.017129</pub-id>
  <?supplied-pmid 31537750?>
  <pub-id pub-id-type="pmid">31537750</pub-id>
 </element-citation>
</ref>
